Up in Smoke, Why India’s Tobacco Taxes Are Failing to Break the Addiction
One puff of a cigarette, within seconds, infuses the human bloodstream with nicotine—the acutely addictive and carcinogenic chemical in tobacco. The molecule binds to the brain’s cellular receptors, sparking the dopaminergic reward system that keeps smokers hooked. Additives like menthol ensure nicotine lingers longer, affecting the central nervous system and deepening dependency.
This is not a moral failing; it is a chemical process, meticulously engineered by an industry that profits from addiction. And in India, the world’s second-largest consumer and producer of tobacco, that industry claims 1.35 million lives every year—from cancer, lung disease, cardiovascular disease, and stroke, according to the World Health Organization (WHO).
The Union Budget, presented annually, routinely raises the price of a cigarette stick through additional excise duties. The latest increase, effective February 1, pushed cigarette prices up by 15-30%. Yet even this hike falls short of the WHO’s benchmark for effective tobacco taxation: taxes should account for at least 75% of the retail price. In India, they currently account for only 53%.
The Science of Addiction
To understand why taxation matters, one must first understand what tobacco does to the body. Nicotine is not a harmless stimulant; it is one of the most addictive substances known. Within seconds of inhalation, it reaches the brain, where it binds to nicotinic acetylcholine receptors. This triggers a flood of dopamine—the neurotransmitter associated with pleasure and reward—creating a powerful reinforcement loop.
Over time, the brain adapts. Receptors multiply. Tolerance builds. The smoker needs more nicotine to achieve the same effect. Withdrawal becomes painful: irritability, anxiety, difficulty concentrating. The smoker is no longer choosing to smoke; they are smoking to avoid withdrawal.
Additives compound the problem. Menthol, for example, does not just flavour cigarettes; it anaesthetises the throat, making the smoke easier to inhale. It also slows the metabolism of nicotine, causing it to linger longer in the body. The cigarette is not a simple product; it is a carefully designed drug delivery system.
The Tax Evidence
Given this reality, taxation is not just a revenue measure; it is a public health intervention. Higher prices deter initiation, especially among price-sensitive young people. They encourage cessation among current smokers. And they reduce consumption among those who continue to smoke.
The evidence is robust. A 2017 peer-reviewed study examined the association between state-level VAT rates and tobacco use in India. It found that every 10% increase in cigarette VAT rates was associated with a decrease of 0.9% to 17.2% in cigarette smoking by men, depending on the measure used. For dual use of cigarettes and beedis, the decrease ranged from 6.5% to 21.6%.
As Upendra Bhojani, senior fellow at the Institute of Public Health, Bengaluru, notes, different surveys show different magnitudes of decline, but the direction is consistent: higher taxes reduce consumption. The Global Adult Tobacco Survey and the Tobacco Control Policy India survey both confirm this pattern.
Yet historically, tax increases on tobacco products have not kept pace with consumer inflation. This means that in real terms, tobacco has become more affordable, not less. The recent increase is welcome, but it still leaves India far below the WHO’s 75% benchmark.
The Beedi Anomaly
If cigarettes are under-taxed, beedis are even more problematic. The GST rate on beedis has been reduced to 18%. This is a fraction of the tax on cigarettes, and far below what public health experts recommend.
Beedis are more prevalent than cigarettes in India. They are the second most prevalent form of tobacco use after smokeless tobacco. Crucially, they are consumed primarily by lower-income populations—the very groups most sensitive to price increases. A low tax on beedis is thus a regressive policy that harms the poor while protecting an industry that kills them.
Experts argue that the GST rate on beedis should be raised to at least 40%. Anything less is a missed opportunity to save lives and reduce health inequalities.
Industry Interference
The gap between evidence and policy is not accidental. It is the result of sustained, sophisticated interference by the tobacco industry. As Andrew Black, acting head of the secretariat of the WHO Framework Convention on Tobacco Control (WHO FCTC), warned in a release, the industry’s tactics go far beyond conventional lobbying.
“This is not just lobbying; it is a deliberate strategy to try to derail consensus and weaken measures to further the treaty’s implementation,” Black said. The industry has been shown to manipulate delegations, spread misinformation, and undermine global tobacco control efforts.
In India, the pattern is clear. “All sectors of the tobacco industry—cigarette, beedis, and smokeless tobacco companies—have been shown to influence tobacco control-related policy in their favour,” said Dr. Bhojani. The India Tobacco Industry Interference Index tracks these efforts, showing that while there has been marginal improvement over the years, the problem persists.
The WHO FCTC, to which India is a party, requires signatories to protect their public health policies from commercial and other vested interests of the tobacco industry. This is not a suggestion; it is a treaty obligation. Yet implementation remains uneven.
The Environmental Toll
Tobacco kills not just through its use, but through its entire lifecycle. The recent 11th session of the Conference of the Parties (COP) to the FCTC, held in Geneva in November 2025, devoted significant attention to this dimension. Parties discussed measures to prevent and manage the waste produced by tobacco and nicotine products and related electronic devices.
The numbers are staggering. Trillions of cigarette butts—containing plastic filters and leaching harmful chemicals—pollute the environment each year. They are the most common form of litter globally, contaminating soil and water, harming wildlife, and releasing toxic substances into ecosystems.
The COP decisions on tobacco control and the environment represent an important step forward. They acknowledge that the industry’s harms are not confined to human health but extend to the planet itself. They create a framework for holding the industry accountable for the damage it has caused.
Beyond Tobacco
Prashanth N. Srinivas, senior fellow at the Institute of Public Health, Bengaluru, offers a broader perspective. “The experiences with tobacco industry interference and tobacco-related regulation need to be transferred to other health-harming industries, including the alcohol industry and the food processing industry,” he told The Hindu.
This is a crucial insight. The tactics used by the tobacco industry—lobbying, misinformation, manipulation of delegations—are not unique to tobacco. They are employed by any industry whose profits depend on selling products that harm health. The alcohol industry, the ultra-processed food industry, the sugar industry—all have been shown to interfere with public health policy.
India’s experience with tobacco regulation offers lessons for how to counter these tactics. Transparency, independent research, civil society mobilization, and robust implementation of treaty obligations are all essential. The fight against tobacco is a template for the broader fight against the commercial determinants of health.
Conclusion: The Price of Inaction
Tobacco kills 1.35 million Indians every year. That is more than the population of many countries. It is a preventable tragedy, made worse by policy choices that fall short of what evidence demands.
The recent tax increase is a step in the right direction, but it is not enough. India must raise tobacco taxes to at least the WHO benchmark of 75% of retail price. It must increase the GST rate on beedis to at least 40%. It must strengthen implementation of the FCTC and protect policy from industry interference.
Every year of delay means more deaths. Every percentage point below the benchmark means more young people initiated into addiction. Every concession to industry means more families devastated by preventable disease.
The science is clear. The evidence is robust. The treaty obligations are unambiguous. What remains is political will. The question is whether India will summon it.
Q&A: Unpacking India’s Tobacco Tax Challenge
Q1: Why is taxation considered an effective tool for reducing tobacco consumption?
A: Taxation works through multiple mechanisms. Higher prices deter initiation, especially among price-sensitive young people who might otherwise start smoking. They encourage cessation among current smokers by increasing the financial cost of continuing. And they reduce consumption among those who continue to smoke. The evidence is robust: studies in India have shown that every 10% increase in cigarette taxes is associated with significant reductions in smoking prevalence, particularly among men and dual users of cigarettes and beedis. The WHO recommends that taxes account for at least 75% of retail price to achieve meaningful public health impact.
Q2: How does India’s current tax level on cigarettes compare to international benchmarks?
A: India’s recent taxes on cigarettes account for only about 53% of the retail price. This is well below the WHO’s 75% benchmark for significantly deterring consumption, especially among young and low-income users. While the last couple of years have seen government efforts to raise taxes, they still fall short of international best practice. Moreover, historically, tax increases have not kept pace with consumer inflation, meaning tobacco products have become more affordable in real terms rather than less.
Q3: What is the problem with the current GST rate on beedis?
A: The GST rate on beedis has been reduced to 18%, a fraction of the tax on cigarettes and far below what public health experts recommend. This is particularly problematic because beedis are more prevalent than cigarettes in India, are the second most prevalent form of tobacco use after smokeless tobacco, and are consumed primarily by lower-income populations—the very groups most sensitive to price increases. Experts argue that the GST rate on beedis should be raised to at least 40% to reduce consumption and health inequalities.
Q4: How does the tobacco industry interfere with tobacco control policy in India?
A: The tobacco industry employs a range of tactics, from conventional lobbying to outright attempts to manipulate delegations and spread misinformation. All sectors of the industry—cigarette, beedi, and smokeless tobacco companies—have been shown to influence policy in their favour. The India Tobacco Industry Interference Index tracks these efforts, showing persistent challenges despite some marginal improvement over the years. As a party to the WHO Framework Convention on Tobacco Control, India has an obligation to protect its public health policies from such interference.
Q5: What broader lessons does the tobacco experience offer for regulating other health-harming industries?
A: The tobacco experience offers a template for countering the commercial determinants of health. The same tactics—lobbying, misinformation, manipulation—are employed by the alcohol industry, the ultra-processed food industry, and the sugar industry. The strategies that work against tobacco—transparency, independent research, civil society mobilization, robust implementation of regulations—are transferable to these other sectors. India’s experience with tobacco regulation can inform a broader approach to protecting public health from industries whose profits depend on harm.
